Biol Reprod Lalor Postdoctoral Fellowships -- Application Deadline January 15, 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow My Folders
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HOLINKA, C. F.
Right arrow Articles by GURPIDE, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HOLINKA, C. F.
Right arrow Articles by GURPIDE, E.
Agricola
Right arrow Articles by HOLINKA, C. F.
Right arrow Articles by GURPIDE, E.

Biology of Reproduction, Vol 22, 913-926, Copyright © 1980 by Society for the Study of Reproduction

Comparison of Effects of Estetrol and Tamoxifen with Those of Estriol and Estradiol on the Immature Rat Uterus

C. F. HOLINKA 1, R. S. BRESSLER 1, D. R. ZEHR 1, , and E. GURPIDE 1

1 Department of Obstetrics and Gynecology (Division of Reproductive Biology), Department of Biochemistry and Department of Anatomy, Mount Sinai School of Medicine (CUNY), New York, New York 10029


The estrogenic effects on this immature rat uterus of estetrol [1,3,5(10)-estratriene-3,15agr, 16agr, 17beta-tetrol] (E4), a major metabolite of placental estrogens in the human fetus, and of tamoxifen (TAM), an antiestrogen, were compared with those of estradiol (E2) and estriol (E3). The compounds were injected s.c. daily, for 3 days, into 22- or 23-day-old Sprague-Dawley rats at a dose of 50 µg/100 g BW of E4 or TAM, and 1 µg/100 g BW of E2 or E3. Tissue was collected 24 to 27 h after the third injection.

Both E4 and TAM increased uterine cytosol progesterone receptor (PR) content and PR/DNA. Progesterone receptor levels per mg DNA were 1.7, 2.8 and 5.1 pmol in the control, E4 and TAM groups, respectively. Both compounds showed estrogenic activity in raising uterine wet weight and content of total and soluble (cytosol) protein. Tamoxifen augmented DNA content but the effect of E4 on this parameter was statistically significant in only one of two series of experiments. Specific induction of soluble protein, assessed by the ratio cytosol/total protein, was noted after E2 or E3 injection, but not after treatment with E4 or TAM.

Evaluation of morphologic changes in luminal and glandular epithelium by light and electron microscopy indicated enhanced synthetic and secretory activity after administration of all four compounds. Estradiol and TAM changed the shape of luminal epithelial cells from cuboidal to tall columnar, developed prominent Golgi systems and rough endoplasmic reticulum, and promoted the formation of secretory granules. Similar but less pronounced ultrastructural changes were observed after E3 or E4 treatment: the height of the luminal columnar epithelium was lower, the microvilli were shorter and the secretory granules were absent. The ultrastructural changes in glandular epithelium paralleled those found in the luminal epithelium. Cell degeneration was observed in luminal and glandular epithelium after E3 or E4 treatment and, to a small degree, after TAM treatment. Estradiol produced this effect in glandular but not in luminal epithelium. The phenolic steroids, but not TAM, increased the number of uterine eosinophils significantly. TAM raised the endometrial/myometrial ratio of cross-sectional areas significantly, whereas E2, E3 or E4 showed a tendency to lower those ratios.

In general, E2 treatment promoted the most marked changes, followed by TAM, E3 and E4. On the basis of the present biochemical and morphologic results, it is concluded that E4 and TAM have estrogenic effects on the immature rat uterus. However, the estrogenic potency of E4 relative to E2 or E3 was low at the dosage and timing of administration used in these experiments; effects of E4 introduced into the circulation at a constant rate were not evaluated. These results suggest that the conversion of E2 to E4 in the human fetus might represent an efficient mechanism of inactivation of the placental hormone.

Note:
ACKNOWLEDGMENTS Miss Elizabeth Storch provided skillful technical assistance in the ultrastructural studies.

Submitted on November 14, 1979
Accepted on January 25, 1980




This article has been cited by other articles:


Home page
 Reproductive SciencesHome page
B. S. Komm
Review Article: A New Approach to Menopausal Therapy: The Tissue Selective Estrogen Complex
Reproductive Sciences, December 1, 2008; 15(10): 984 - 992.
[Abstract] [PDF]

Home page
 Exp. Biol. Med.Home page
K. P. Nephew, E. Osborne, R. A. Lubet, C. J. Grubbs, and S. A. Khan
Effects of Oral Administration of Tamoxifen, Toremifene, Dehydroepiandrosterone, and Vorozole on Uterine Histomorphology in the Rat
Experimental Biology and Medicine, March 1, 2000; 223(3): 288 - 294.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1980 by the Society for the Study of Reproduction.